The innovation paradox: pharmaceutical marketing exclusivity and incentives for drug development
ConclusionsIf the length of the pre ‐market process correlates with particular drug types, disease targets, or studied outcomes, we may be offering an inadequate incentive in entire areas of medicine where we have a critical need for new treatments.
Source: Journal of Pharmaceutical Health Services Research - Category: Drugs & Pharmacology Authors: Erika Lietzan,
Kristina M. L. Acri n ée Lybecker Tags: Research Paper Source Type: research
More News: Drugs & Pharmacology